Displaying 1 - 50 of 249 results
Released Company Title Industry Topic
27 May 2026
17:45 CEST
GIMV Report ordinary & special general meeting of May 27, 2026 30202010 Asset Managers and Custodians Other subject
27 May 2026
17:45 CEST
GIMV Verslag gewone & bijzondere algemene vergadering 27 mei 2026 30202010 Asset Managers and Custodians Other subject
27 May 2026
17:45 CEST
GIMV Report ordinary & special general meeting of May 27, 2026 30202010 Asset Managers and Custodians Other subject
27 May 2026
07:30 CEST
GIMV Trading update 30202010 Asset Managers and Custodians Other subject
27 May 2026
07:30 CEST
GIMV Trading update 30202010 Asset Managers and Custodians Other subject
27 May 2026
07:30 CEST
GIMV Trading update 30202010 Asset Managers and Custodians Other subject
30 Apr 2026
07:30 CEST
GIMV Nieuwe Gimv Anchor investering: acquisitie van een belang van 5% in Azelis 30202010 Asset Managers and Custodians Other subject
30 Apr 2026
07:30 CEST
GIMV New Gimv Anchor investment: acquisition of 5% shareholding in Azelis 30202010 Asset Managers and Custodians Other subject
30 Apr 2026
07:30 CEST
GIMV New Gimv Anchor investment: acquisition of 5% shareholding in Azelis 30202010 Asset Managers and Custodians Other subject
27 Apr 2026
17:45 CEST
GIMV Oproeping tot de jaarlijkse algemene vergadering van 27 mei 2026 30202010 Asset Managers and Custodians Other subject
27 Apr 2026
17:45 CEST
GIMV Convocation annual general meeting of May 27, 2026 30202010 Asset Managers and Custodians Other subject
27 Apr 2026
17:45 CEST
GIMV Convocation annual general meeting of May 27, 2026 30202010 Asset Managers and Custodians Other subject
24 Mar 2026
07:30 CET
GIMV Gimv secures new EUR 400 million revolving credit facility to support accelerated growth ambitions 30202010 Asset Managers and Custodians Other subject
24 Mar 2026
07:30 CET
GIMV Gimv verzekert zich van een nieuwe Revolving Credit Facility van EUR 400 miljoen ter ondersteuning van de versnelde groeiambities 30202010 Asset Managers and Custodians Other subject
05 Mar 2026
07:30 CET
GIMV Share buyback finalized 30202010 Asset Managers and Custodians Other subject
05 Mar 2026
07:30 CET
GIMV Share buyback finalized 30202010 Asset Managers and Custodians Other subject
05 Mar 2026
07:30 CET
GIMV Inkoop eigen aandelen afgerond 30202010 Asset Managers and Custodians Other subject
05 Mar 2026
07:30 CET
GIMV Share buyback finalized 30202010 Asset Managers and Custodians Other subject
27 Feb 2026
07:30 CET
GIMV Share buyback – update 30202010 Asset Managers and Custodians Other subject
27 Feb 2026
07:30 CET
GIMV Inkoop eigen aandelen – update 30202010 Asset Managers and Custodians Other subject
27 Feb 2026
07:30 CET
GIMV Share buyback – update 30202010 Asset Managers and Custodians Other subject
20 Feb 2026
07:30 CET
GIMV Announcement of share buyback in the context of a share purchase plan 30202010 Asset Managers and Custodians Other subject
20 Feb 2026
07:30 CET
GIMV Aankondiging inkoop eigen aandelen in het kader van een aandelenaankoopplan 30202010 Asset Managers and Custodians Other subject
20 Feb 2026
07:30 CET
GIMV Announcement of share buyback in the context of a share purchase plan 30202010 Asset Managers and Custodians Other subject
19 Feb 2026
07:00 CET
GIMV Gimv builds on strong growth to deliver solid results Record investment level in a shortened financial year of 9 months 30202010 Asset Managers and Custodians Other subject
19 Feb 2026
07:00 CET
GIMV Gimv builds on strong growth to deliver solid results Record investment level in a shortened financial year of 9 months 30202010 Asset Managers and Custodians Other subject
19 Feb 2026
07:00 CET
GIMV Gimv zet sterk groeitraject voort met solide resultaten Recordinvesteringen in boekjaar van 9 maanden 30202010 Asset Managers and Custodians Other subject
26 Jan 2026
17:45 CET
GIMV Gimv increases focus on strategic objectives and discontinues activities for new Life Sciences investments 30202010 Asset Managers and Custodians Other subject
26 Jan 2026
17:45 CET
GIMV Gimv verhoogt focus op strategische doelstellingen en discontinueert activiteiten voor nieuwe Life Sciences investeringen 30202010 Asset Managers and Custodians Other subject
26 Jan 2026
17:45 CET
GIMV Gimv increases focus on strategic objectives and discontinues activities for new Life Sciences investments 30202010 Asset Managers and Custodians Other subject
26 Jan 2026
17:45 CET
GIMV Gimv increases focus on strategic objectives and discontinues activities for new Life Sciences investments 30202010 Asset Managers and Custodians Other subject
20 Jan 2026
07:30 CET
GIMV Gimv leads € 51 million Series B investment round in Exciva to advance innovative Alzheimer’s therapy 30202010 Asset Managers and Custodians Other subject
20 Jan 2026
07:30 CET
GIMV Gimv leidt een Series B investeringsronde van EUR 51 miljoen in Exciva voor verdere ontwikkeling van een innovatieve Alzheimerbehandeling 30202010 Asset Managers and Custodians Other subject
20 Jan 2026
07:30 CET
GIMV Gimv leads € 51 million Series B investment round in Exciva to advance innovative Alzheimer’s therapy 30202010 Asset Managers and Custodians Other subject
16 Jan 2026
07:30 CET
GIMV Gimv verkoopt meerderheidsbelang in ALT Technologies aan CCL Industries 30202010 Asset Managers and Custodians Other subject
16 Jan 2026
07:30 CET
GIMV Gimv sells majority stake in ALT Technologies to CCL Industries 30202010 Asset Managers and Custodians Other subject
16 Jan 2026
07:30 CET
GIMV Gimv sells majority stake in ALT Technologies to CCL Industries 30202010 Asset Managers and Custodians Other subject
27 Nov 2025
07:30 CET
GIMV Gimv joins forces with CNP to accelerate the global expansion of Equine Care Group 30202010 Asset Managers and Custodians Other subject
27 Nov 2025
07:30 CET
GIMV Gimv joins forces with CNP to accelerate the global expansion of Equine Care Group 30202010 Asset Managers and Custodians Other subject
27 Nov 2025
07:30 CET
GIMV Gimv bundelt krachten met CNP om de wereldwijde expansie van Equine Care Group te versnellen 30202010 Asset Managers and Custodians Other subject
20 Nov 2025
07:00 CET
GIMV Solid growth performance in the first half of FY 2025 30202010 Asset Managers and Custodians Other subject
20 Nov 2025
07:00 CET
GIMV Solide groei in eerste helft boekjaar 2025 30202010 Asset Managers and Custodians Other subject
20 Nov 2025
07:00 CET
GIMV Solid growth performance in the first half of FY 2025 30202010 Asset Managers and Custodians Other subject
05 Nov 2025
07:30 CET
GIMV Gimv bundelt krachten met Quality Guard om een toonaangevend softwareplatform voor voedselveiligheid in Europa uit te bouwen 30202010 Asset Managers and Custodians Other subject
05 Nov 2025
07:30 CET
GIMV Gimv partners with Quality Guard to establish a leading software platform for food safety compliance across Europe 30202010 Asset Managers and Custodians Other subject
05 Nov 2025
07:30 CET
GIMV Gimv partners with Quality Guard to establish a leading software platform for food safety compliance across Europe 30202010 Asset Managers and Custodians Other subject
22 Oct 2025
07:30 CEST
GIMV Gimv Life Sciences realizes successful exit with the sale of its stake in Imcheck Therapeutics to Ipsen 30202010 Asset Managers and Custodians Other subject
22 Oct 2025
07:30 CEST
GIMV Gimv Life Sciences realizes successful exit with the sale of its stake in Imcheck Therapeutics to Ipsen 30202010 Asset Managers and Custodians Other subject
22 Oct 2025
07:30 CEST
GIMV Gimv Life Sciences realiseert succesvolle exit met de verkoop van belang in Imcheck Therapeutics aan Ipsen. 30202010 Asset Managers and Custodians Other subject
26 Sep 2025
07:30 CEST
GIMV Gimv en EGS Beteiligungen versterken hun strategische steun aan Spineart met kapitaalverhoging van 25 miljoen CHF ter versnelling van wereldwijde groei 30202010 Asset Managers and Custodians Other subject